Is there a generic for Invert sugar?

The FDA Orange Book does not currently list an approved generic (ANDA) for Invert sugar. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Invert sugar?

TRAVERT 10% IN PLASTIC CONTAINER (NDA 016717, BAXTER HLTHCARE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Invert sugar are approved?

Invert sugar is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Invert sugar

Invert sugar is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:TRAVERT 10% IN PLASTIC CONTAINER · NDA 016717

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
TRAVERT 10% IN PLASTIC CONTAINER	BAXTER HLTHCARE	NDA 016717	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Invert sugar — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo